Larson Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74K Buy
95
+61
+179% +$1.01K ﹤0.01% 3255
2026
Q2
$496 Buy
34
+9
+36% +$87 ﹤0.01% 3488
2026
Q1
$186 Sell
25
-338
-93% -$3.56K ﹤0.01% 3462
2025
Q4
$4.27K Buy
363
+219
+152% +$2.36K ﹤0.01% 2520
2025
Q3
$1.11K Buy
144
+133
+1,209% +$932 ﹤0.01% 2891
2025
Q2
$80 Sell
11
-69
-86% -$557 ﹤0.01% 3192
2025
Q1
$759 Buy
80
+65
+433% +$812 ﹤0.01% 2466
2024
Q4
$247 Hold
15
– – ﹤0.01% 2384
2024
Q3
$221 Hold
15
– – ﹤0.01% 2340
2024
Q2
$208 Buy
+15
New +$213 ﹤0.01% 2053

Other funds holding NEO

Larson Financial Group's NEO Position: Q3 2026 in Review

Larson Financial Group increased its NeoGenomics (NEO) stake by 179% in Q3 2026, buying an estimated $1.01K and bringing the position to 95 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

Larson Financial Group first reported a position in NEO in Q2 2024 and has held it in 10 quarters since. The position peaked at $4.27K in Q4 2025. 259 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Larson Financial Group held 95 shares of NeoGenomics worth $1.74K as of Q3 2026.
  • Larson Financial Group bought 61 NeoGenomics shares in Q3 2026, an estimated $1.01K.
  • NeoGenomics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3255 holding.
  • Larson Financial Group first reported a position in NeoGenomics in Q2 2024 and has held it in 10 quarters since.
  • Larson Financial Group's NeoGenomics position peaked at $4.27K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.